When James E. Golden was diagnosed with prostate cancer he was suddenly faced with the daunting task of interviewing surgeons on “something I know nothing about,” Golden said. Nearly a year later, ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

An Indian-origin surgeon removed a cancer patient's prostate from 35 miles away in what was reported as a first-of-its-kind ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

Prostate cancer surgery removes the prostate, but for men with high-risk disease, it doesn't always end the story. Cancer can return, spread, or require additional treatment. Researchers are looking ...

Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...

A national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of the prostate, with follow-up of up to 20 years. Men who ...

A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...

The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...

Results show excellent early functional recovery in clinically complex patients with advanced prostate cancer ... Read More The post Orthocell nerve repair product Remplir shows promise in prostate ...

What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...